Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review

Effective dosing of isavuconazole in patients supported by extracorporeal membrane oxygenation (ECMO) is important due to the role of isavuconazole as a first-line treatment in patients with influenza- and COVID-19-associated pulmonary aspergillosis. To date, robust pharmacokinetic data in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Mertens, Beatrijs, Elkayal, Omar, Dreesen, Erwin, Wauters, Joost, Meersseman, Philippe, Debaveye, Yves, Degezelle, Karlien, Vermeersch, Pieter, Gijsen, Matthias, Spriet, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376546/
https://www.ncbi.nlm.nih.gov/pubmed/37508181
http://dx.doi.org/10.3390/antibiotics12071085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376546/
https://www.ncbi.nlm.nih.gov/pubmed/37508181
http://dx.doi.org/10.3390/antibiotics12071085

Ejemplares similares